Mukka Proteins Performance
- Today's Low
- ₹22
- Today's High
- ₹23
- 52 Week Low
- ₹18
- 52 Week High
- ₹33
- Open Price₹23
- Previous Close₹23
- Volume128,764
- 50 DMA₹23.19
- 100 DMA₹23.47
- 200 DMA₹25.13
Mukka Proteins Chart
Investment Returns
- Over 1 Month -6.66%
- Over 3 Month -2.73%
- Over 6 Month -9.16%
- Over 1 Year -27.05%
Smart Investing Starts Here Start SIP with Mukka Proteins for Steady Growth!
Mukka Proteins Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 13
- PEG Ratio
- 1.1
- Market Cap Cr
- 672
- P/B Ratio
- 1.4
- Average True Range
- 0.84
- EPS
- 1.74
- Dividend Yield
- 0
- MACD Signal
- 0.19
- RSI
- 36.72
- MFI
- 54.28
Latest Stock News Updates
Under the contract, the JV will treat and dispose of legacy leachate accumulated in Mittaganahalli and Kannur landfill sites
- Business Standard
- 5 months 2 weeks ago
Mukka Proteins' shares rose over 8% after securing multiple supply orders, including significant deals with Avanti Feeds and Padma Feed, boosting its order book to 200 crore. The company reported a 151% YoY profit growth in Q3FY25, despite a revenue decline.
- livemint
- 1 year 2 months ago
Food Products company Mukka Proteins announced Q4FY24 & FY24 results: PAT for Q4 FY24, increased by 141.53% to Rs 29.15 crore from 12.07 crore in Q3FY24 (QoQ comparison) and increased by 32.99% in Q4FY24 from Rs 21.92 crore in Q4FY23 (YoY comparison) For the entire FY24, PAT increased by 56.35% to Rs 74.31 crore, from Rs 47.52 crore in FY23 On a QoQ basis, the EBITDA margins increased by 177.47%, to 14.38% in Q4FY24 from 5.18% in Q3FY24, indicating 920 bps improvement in the margins EBIDTA has improved by 37.77% to Rs 36.92 crore in Q4FY24 from Rs 26.80 crore in Q3FY24 PAT % as a % of Revenue has improved by 386.44%, to 11.36% in Q4FY24 from 2.33% in Q3FY24 and has improved by 117.96% compared to Q4FY23. On this occasion, Mohammed Haris, MD and CEO, Mukka Proteins said "We are extremely proud of the strong operational performance of the company in Q4FY24. The improvement in the margins clearly indicates that the management is focused on improving the profitability going forward as well. The use of IPO proceeds in the working capital requirements has boarded extremely well with the plans visualized by the management of the company. The sector promises to witness strong growth momentum going further in FY25 and in recent times the support from the Government through various schemes like Pradhan Mantri Matsya Sampada Yojana (PMMSY), Fisheries and Aquaculture Infrastructure Development Fund, Blue revolution 2.0 will only boost the prospects of the industry going forward. Our aim will be to surpass the industry growth and ensure that all our stakeholders including investors are extremely happy with the company’s performance”. Result PDF
- Trendlyne
- 2 years ago
Mukka Proteins Financials
Mukka Proteins Technicals
EMA & SMA
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹23.37
- 50 Day
- ₹23.19
- 100 Day
- ₹23.47
- 200 Day
- ₹25.13
Resistance and Support
- R3 23.57
- R2 23.26
- R1 22.83
- S1 22.09
- S2 21.78
- S3 21.35
Mukka Proteins Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-05-15 | Audited Results & Raising of funds | |
| 2026-02-12 | Quarterly Results | (Revised) |
| 2025-11-12 | Quarterly Results | |
| 2025-08-13 | Quarterly Results & Others | To consider other business matters. |
| 2025-05-15 | Audited Results |
About Mukka Proteins
- NSE Symbol
- MUKKA
- BSE Symbol
- 544135
- Managing Director & CEO
- Mr. Kalandan Mohammed Haris
- ISIN
- INE0CG401037
Similar Stocks to Mukka Proteins
Popular Stocks
Mukka Proteins FAQs
Mukka Proteins share price is ₹22 As on 24 May, 2026 | 09:55
The Market Cap of Mukka Proteins is ₹672.3 Cr As on 24 May, 2026 | 09:55
The P/E ratio of Mukka Proteins is 13 As on 24 May, 2026 | 09:55
The PB ratio of Mukka Proteins is 1.4 As on 24 May, 2026 | 09:55
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.